Evidence map›Paper›PMID 19128015›Full record

ArticleJournal of medicinal chemistry2009

Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity.

Iain D Kerr, Ji H Lee, Kailash C Pandey, Amanda Harrison, Mohammed Sajid, Philip J Rosenthal, Linda S Brinen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 167 citations in OpenAlex.

  1. Article
  2. Antiplasmodial Activity of Methylangolensate FromJournal of tropical medicine · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Iain D KerrDepartment of Cellular and Molecular Pharmacology and Department of Pathology, University of California, San Francisco, California 94158, USA.
Ji H Lee
Kailash C Pandey
Amanda Harrison
Mohammed Sajid
Philip J Rosenthal
Linda S Brinen
San Francisco General Hospital · USUniversity of California, San Francisco · US

Funding

X-RAY CRYSTALLOGRAPHYP01AI035707 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROUSH, WILLIAM R · 1995 to 2008
$7.8M
EVALUATION OF FALCIPAIN AS AN ANTIMALARIAL DRUG TARGETR01AI035800 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ROSENTHAL, PHILIP JON · 1999 to 2003
$1.3M
Falcipain Cysteine Proteases of Malaria ParasitesR56AI035800 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ROSENTHAL, PHILIP JON · 2005 to 2005
$368k
MALARIAL HEMOGLOBINASER29AI035800 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ROSENTHAL, PHILIP JON · 1994 to 1998
–
NIAID NIH HHS AI35707NIAID NIH HHS AI35800NIAID NIH HHS P01 AI035707NIAID NIH HHS R01 AI035800NIAID NIH HHS R29 AI035800NIAID NIH HHS R56 AI035800
6 · The paper itself

Abstract

Falcipain-2 and falcipain-3 are critical hemoglobinases of Plasmodium falciparum, the most virulent human malaria parasite. We have determined the 2.9 A crystal structure of falcipain-2 in complex with the epoxysuccinate E64 and the 2.5 A crystal structure of falcipain-3 in complex with the aldehyde leupeptin. These complexes represent the first crystal structures of plasmodial cysteine proteases with small molecule inhibitors and the first reported crystal structure of falcipain-3. Our structural analyses indicate that the relative shape and flexibility of the S2 pocket are affected by a number of discrete amino acid substitutions. The cumulative effect of subtle differences, including those at "gatekeeper" positions, may explain the observed kinetic differences between these two closely related enzymes.

Indexed as

AnimalsCatalytic DomainCrystallizationCrystallography, X-RayCysteine EndopeptidasesCysteine Proteinase InhibitorsKineticsLeupeptinsModels, MolecularPlasmodium falciparumSubstrate SpecificityCysteine EndopeptidasesCysteine Proteinase Inhibitorsfalcipain 2falcipain 3leupeptinLeupeptins

Identifiers

PMID19128015
PMCPMC2651692
OpenAlexW2125677289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.